Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Wen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cancer Gene Therapy|August 7, 1998
A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growthG W Demers, M P Harris, S F Wen, et al.
Cytokine & Growth Factor Reviews|August 19, 2007
Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancerT L Nagabhushan, D C Maneval, W F Benedict, et al.
Urology|May 1, 1999
Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodentsH Engler, S C Anderson, T R Machemer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 18, 2001
Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapyA Rahman, V Tsai, A Goudreau, et al.
In Vitro Cellular & Developmental Biology. Animal|March 1, 1995
Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathwayR A Gjerset, H Fakhrai, D L Shawler, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|August 22, 2012
Value of a skin island flap as a postoperative predictor of vascularized fibula graft viability in extensive diaphyseal bone defect reconstructionQ-F Guo, Z-H Xu, S-F Wen, et al.
Cancer Gene Therapy|December 29, 2000
Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft modelsS F Wen, L Xie, M McDonald, et al.
Human Gene Therapy|September 1, 1994
Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancerK N Wills, D C Maneval, P Menzel, et al.
Journal of Virology|August 17, 2001
Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirusK N Wills, I A Atencio, J B Avanzini, et al.
Cancer Gene Therapy|January 10, 2002
Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cellsM Hirai, D LaFace, S Robinson, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer Gene Therapy|August 7, 1998
A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growthG W Demers, M P Harris, S F Wen, et al.
Cytokine & Growth Factor Reviews|August 19, 2007
Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancerT L Nagabhushan, D C Maneval, W F Benedict, et al.
Urology|May 1, 1999
Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodentsH Engler, S C Anderson, T R Machemer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 18, 2001
Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapyA Rahman, V Tsai, A Goudreau, et al.
In Vitro Cellular & Developmental Biology. Animal|March 1, 1995
Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathwayR A Gjerset, H Fakhrai, D L Shawler, et al.
Orthopaedics & Traumatology, Surgery & Research : OTSR|August 22, 2012
Value of a skin island flap as a postoperative predictor of vascularized fibula graft viability in extensive diaphyseal bone defect reconstructionQ-F Guo, Z-H Xu, S-F Wen, et al.
Cancer Gene Therapy|December 29, 2000
Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft modelsS F Wen, L Xie, M McDonald, et al.
Human Gene Therapy|September 1, 1994
Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancerK N Wills, D C Maneval, P Menzel, et al.
Journal of Virology|August 17, 2001
Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirusK N Wills, I A Atencio, J B Avanzini, et al.
Cancer Gene Therapy|January 10, 2002
Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cellsM Hirai, D LaFace, S Robinson, et al.
Pageof 6